In Q1 2025 we recorded a jump in revenue and earnings due to the first-time consolidation of Bormioli Pharma. Reported revenues in the first quarter of 2025 rose by 11.6% to EUR 520.1 million, while adjusted EBITDA increased by 13.1% to EUR 91.5 million. The organic development compared to the pro forma figures for the prior-year quarter shows a decline and reflects a shift in revenues in the syringe business and subdued demand for moulded glass especially from the cosmetics sector. Read our Corporate News https://lnkd.in/ej6PmYK9 #innovatingforabetterlife #gerresheimer #pharma #cosmetics #sustainability #drugdelivery #q1fy2025
Optimizing the melting process in a glass furnace is crucial for improving energy efficiency, reducing emissions, and enhancing the quality of the final glass product.
2dHerzlichen Glückwunsch 🎉